Abstract
AbstractThis project explores the nature of the human intestinal microbiome in healthy children and children with recurrent abdominal pain. The overall goal is to obtain a robust knowledge base of the intestinal microbiome in children without evidence of pain or gastrointestinal disease and in those with recurrent abdominal pain (functional abdominal pain (FAP) and FAP associated with changes in bowel habits, i.e., irritable bowel syndrome or IBS). Specific aims include: 1. Characterize the composition of the gut microbiome in healthy children by DNA sequencing. 2. Determine the presence of disease-specific organism signatures of variable gut microbiomes in children with recurrent abdominal pain. 3. Perform functional gut metagenomics by evaluation of whole community gene expression profiles and discovery of disease-specific pathway signatures. Multiple strategies have been deployed to navigate and understand the nature of the intestinal microbiome in childhood. These strategies included 454 pyrosequencing-based strategies to sequence 16S rRNA genes and understand the detailed composition of microbes in healthy and disease groups. Microarray-based hybridization with the PhyloChip and quantitative real-time PCR (qPCR) probes were applied as complementary strategies to gain an understanding of the intestinal microbiome from various perspectives. Data collected and analyzed during the HMP UH2 Demo project, from a set of healthy and IBS children (7-12 yo) may enable the identification of core microbiomes in children, in addition to variable components that may distinguish healthy from diseased pediatric states. Twenty-two children with IBS and twenty-two healthy children were enrolled and analyzed in the UH2 phase of this study. The planned enrollment targets for the UH2/3 phases include 50 healthy children, 50 children with FAP and 50 children with IBS (minimum of 3 time points per child). We are currently analyzing the dataset for the presence of disease-specific signatures in the human microbiome, and correlating these microbial signatures with pediatric health or IBS disease status in addition to IBS subtype (e.g., diarrhea-vs constipation-predominant). In the next phase, whole genome shotgun sequencing and metatranscriptomics will be performed with a subset of children in each group. This study explores the nature of core and variable human microbiome in pre-adolescent healthy children and children with IBS.
Highlights
This manuscript is part of a pilot effort on the part of NIH staff and the Nature publishing group to provide a more convenient archive for "marker papers" to be published
The length of the publication moratorium is one year from the date of initial data release. This project explores the nature of the human intestinal microbiome in healthy children and children with recurrent abdominal pain
The overall goal is to obtain a robust knowledge base of the intestinal microbiome in children without evidence of pain or gastrointestinal disease and in those with recurrent abdominal pain (functional abdominal pain (FAP) and FAP associated with changes in bowel habits, i.e., irritable bowel syndrome or IBS)
Summary
The only metagenomic 16S sequencing method utilized in this study was 454 pyrosequencing (GS FLX with Titanium chemistry) using bar-coded universal bacterial primers 27F and 534R (V1V3 region), and primers 357F and 936R (V3V5 region). We monitored the data quality of 454 sequencing data and applied the following filtering criteria to select the reads to be included in the analyses: the reads must contain at least 200 nucleotides; the average Qval for each read must be at least 20; the reads should have an exact bar code and exact "A" primer match; the read will be cut at first 'N' or 'n'; and the read can have up to 4 mismatches with the "B" primer. Using these filtering criteria, 75.7% of the 16S 454 reads were selected for analyses. Phylochip hybridization data included redundant probes for each taxa, and internal quality control within each chip
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have